Try our mobile app
Screener
Company
Price and
change
Revenue Growth
last / hist
EV /
LTM
EBITDA
(p75)
EV/
Sales
EBITDA LTM
/ Revenue
FCF LTM
/ Revenue
Next GAAP report
Year div-d yield
FCF Yield LTM
77.9%  /
82.9%
32x
83.7x
20.4x
63.8%
19.5%
..
0.0%
0.9% 
32.7%  /
52.8%
>200x
>200x
27.3x
11.9%
24.6%
..
0.0%
0.9% 
200.0%  /
38.0%
70.8x
177.1x
9.8x
13.8%
5.5%
..
0.0%
0.6% 
22.3%  /
27.5%
45x
180.4x
10.6x
23.6%
24.1%
..
0.0%
2.1% 
7.9%  /
25.2%
50.4x
120.5x
6x
11.8%
59.9%
..
0.0%
9.7% 
2.1%  /
25.2%
64.7x
62.7x
8.2x
12.7%
4.8%
2025-05-13
0.0%
0.6% 
17.3%  /
21.8%
34.3x
44.5x
12.5x
36.5%
27.3%
2025-05-02
0.0%
2.1% 
18.3%  /
21.4%
39x
42.6x
14.6x
37.4%
16.6%
2025-05-07
0.2%
1.1% 
16.7%  /
19.8%
15.4x
>200x
2.8x
18.4%
-21.1%
..
0.0%
-10.5% 
15.0%  /
18.1%
57.2x
145.8x
6.7x
11.7%
9.9%
..
0.0%
1.4% 
14.4%  /
14.4%
40.8x
37.9x
18.6x
45.7%
0.0%
2025-05-01
0.5%
--- 
25.2%  /
13.6%
61.9x
69.3x
20.7x
33.4%
-41.0%
..
0.0%
-1.9% 
10.1%  /
13.2%
32.3x
28.8x
17.6x
54.3%
0.0%
2025-04-24
0.6%
--- 
14.9%  /
13.0%
16.6x
19.1x
3.1x
18.4%
8.7%
..
1.9%
2.8% 
7.6%  /
12.9%
20.8x
28.9x
7x
33.7%
15.2%
2025-06-18
0.6%
2.1% 
12.3%  /
12.5%
20.3x
25.8x
10.8x
53.2%
8.2%
2025-04-25
0.9%
0.8% 
20.6%  /
12.3%
18.1x
20.3x
9.3x
51.6%
-15.5%
..
0.4%
-1.6% 
11.8%  /
11.1%
15.3x
19.3x
5.6x
36.5%
6.2%
2025-04-25
0.5%
1.1% 
7.8%  /
11.0%
11.8x
13.8x
1.6x
13.9%
2.6%
..
2.0%
1.7% 
10.3%  /
11.0%
19.7x
34.1x
7.9x
40.2%
6.3%
2025-06-27
0.0%
0.8% 
10.5%  /
10.7%
16.3x
22.6x
3.1x
19.0%
3.0%
..
0.0%
1.0% 
16.0%  /
9.6%
37.9x
36.6x
10.4x
27.6%
17.2%
2025-04-18
0.0%
1.7% 
12.8%  /
7.8%
19.5x
17.7x
3.7x
19.2%
-59.3%
..
1.3%
-19.7% 
1.0%  /
6.5%
14.6x
16x
0.4x
2.6%
-4.3%
..
2.4%
-9.7% 
-37.0%  /
6.4%
>200x
33.6x
0.1x
-13.5%
-18.0%
..
0.0%
-298.7% 
-57.3%  /
6.3%
15x
16.8x
4.9x
31.7%
-22.1%
..
0.5%
-4.7% 
-0.7%  /
5.5%
10.7x
16.7x
3x
28.3%
2.8%
..
1.2%
1.2% 
5.5%  /
0.5%
28.6x
25.3x
4.7x
16.3%
52.5%
2025-05-03
0.0%
11.9% 
-18.5%  /
-0.4%
>200x
>200x
1.3x
-45.8%
-8.1%
..
0.0%
-53.0% 
1.0%  /
-3.5%
25.1x
26.3x
4.2x
16.7%
4.3%
..
2.7%
1.2% 
-47.9%  /
-4.3%
39.7x
44x
1.5x
3.9%
60.2%
..
0.0%
51.4% 
12.2%  /
-8.0%
18.1x
27.8x
4.5x
24.6%
0.6%
..
0.6%
0.1% 
-7.4%  /
-11.3%
>200x
31.5x
2.4x
-3.3%
-8.6%
..
2.2%
-4.9% 
Trending screeners:
@electric-vehicles
@saas
@cannabis-players
@china
Latin America
India
Dividends
@REITs
@adtech
@airlines
@artificial-intelligence
@auto-parts
@cloud-computing
@crypto
@cybersecurity
@e-commerce
@edtech
@finance-and-technology
@gaming
@internet-of-things
@oil-refining
@real-estate-tech
@renewable-energy
@vaccine-makers

Reviews

2025-03-29
#reports #FF

[FutureFuel](https://eninvs.com/all.php?name=FF) (Chemicals) reported for 2024 q4
(2024-11-08, After Market Close):

- Revenue -32.6% YoY (vs -56.4% in previous quarter and historical rate -1.0%)
- EBITDA -82.6% YoY (vs -133.3% in previous quarter)
- EBITDA margin 6.5% decreased compared to 25.0% same period last year
- Net Debt increased by $23 mln over the past reporting period (12.6% of market cap)
- FCF (LTM) -$0.1 bln (negative), 61.5% of market cap
- EV/EBITDA multiple is 5.5x compared to historical level (75th percentile) of 5.8x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went down -9.5% vs S&P500 +0.2%
2025-03-29
#reports #CLRO

[ClearOne](https://eninvs.com/all.php?name=CLRO) (Communication Equipment) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182690)
(2024-11-15, Before Market Open):

- Revenue -25% YoY (vs -40.0% in previous quarter and historical rate -23.0%)
- EBITDA margin -66.7% decreased compared to -50.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (6.9% of market cap)
- FCF (LTM) -$0 bln (negative), 130.8% of market cap
- EV/Sales multiple is 1.1x

At the opening of the session the share price went down -7.2% vs S&P500 -0.6%
2025-03-29
#reports #CAAS

[China Automotive Systems](https://eninvs.com/all.php?name=CAAS) (Auto Parts) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182688)
(2025-03-28, Before Market Open):

- Revenue +18.9% YoY (vs +18.8% in previous quarter and historical rate +9.8%)
- EBITDA -26.3% YoY (vs +14.3% in previous quarter and historical rate +24.9%)
- EBITDA margin 7.4% decreased compared to 11.9% same period last year
- Net Debt decreased by $53 mln over the past reporting period (36.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 51.3% of market cap
- EV/EBITDA multiple is 0.8x compared to historical level (75th percentile) of 2.4x
- EV/Sales multiple is 0.1x

At the opening of the session the share price went up +1.0% vs S&P500 -0.2%
2025-03-28
#reports #WHLM

[Wilhelmina International](https://eninvs.com/all.php?name=WHLM) (Specialty Business Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182637)
(2024-11-18, Before Market Open):

- Revenue 0% YoY (vs +25.0% in previous quarter and historical rate -15.4%)
- P/E multiple is 18x compared to historical level (75th percentile) of 23x
- P/S multiple is 1x
- Price to book: 0.7x

At the opening of the session the share price went down -0.6% vs S&P500 +0.2%
2025-03-28
#reports #WGO

[Winnebago Industries](https://eninvs.com/all.php?name=WGO) (Motorhome manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182634)
(2025-03-27, Before Market Open):

- Revenue -57.7% YoY (vs -18.0% in previous quarter and historical rate +18.5%)
- EBITDA -87.3% YoY (vs -88.9% in previous quarter and historical rate -27.7%)
- EBITDA margin 2.1% decreased compared to 7.0% same period last year
- Net Debt increased by $39 mln over the past reporting period (3.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 10.4% of market cap
- EV/EBITDA multiple is 9.2x compared to historical level (75th percentile) of 6.8x
- EV/Sales multiple is 0.4x

At the opening of the session the share price went up +9.9% vs S&P500 -0.3%
2025-03-28
#reports #SYPR

[Sypris Solutions](https://eninvs.com/all.php?name=SYPR) (Auto Parts) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182630)
(2025-03-24, Before Market Open):

- Revenue -5.7% YoY (vs +5.9% in previous quarter and historical rate +16.1%)
- EBITDA margin 6.1% increased compared to 2.9% same period last year
- Net Debt decreased by $2 mln over the past reporting period (5.6% of market cap)
- FCF (LTM) -$0 bln (negative), 5.6% of market cap
- EV/EBITDA multiple is 7x compared to historical level (75th percentile) of 12.7x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went up +1.8% vs S&P500 +0.9%
2025-03-28
#reports #PRPO

[Precipio](https://eninvs.com/all.php?name=PRPO) (Diagnostics and Research) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182639)
(2023-11-13, After Market Close):

- Revenue +25% YoY (vs 0.0% in previous quarter and historical rate +48.6%)
- EV/Sales multiple is 8.5x

At the opening of the session the share price went down -7.1%
2025-03-28
#reports #MYSZ

[My Size](https://eninvs.com/all.php?name=MYSZ) (Software — Application) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182644)
(2022-11-17):

- Revenue -66.7% YoY (vs 0.0% in previous quarter and historical rate +94.4%)
- EBITDA margin -100.0% decreased compared to -66.7% same period last year
- Net Debt increased by $2 mln over the past reporting period (43.8% of market cap)
- FCF (LTM) -$0 bln (negative), 21.9% of market cap
- EV/Sales multiple is 0.3x

2025-03-28
#reports #IRIX

[IRIDEX Corporation](https://eninvs.com/all.php?name=IRIX) (Medical Devices) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182623)
(2025-03-27, After Market Close):

- Revenue +8.3% YoY (vs -7.7% in previous quarter and historical rate -5.2%)
- Net Debt increased by $1 mln over the past reporting period (6.8% of market cap)
- FCF (LTM) -$0 bln (negative), 34.2% of market cap
- EV/Sales multiple is 0.3x

At the opening of the session the share price went up +16.1% vs S&P500 -0.2%
2025-03-28
#reports #HQI

[HireQuest](https://eninvs.com/all.php?name=HQI) (Staffing and Employment Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182622)
(2025-03-27, After Market Close):

- Revenue -20% YoY (vs 0.0% in previous quarter and historical rate +20.3%)
- EBITDA 0% YoY (vs -166.7% in previous quarter and historical rate -9.8%)
- EBITDA margin 37.5% increased compared to 30.0% same period last year
- Net Debt decreased by $7 mln over the past reporting period (3.8% of market cap)
- FCF (LTM) +$0 bln (positive), 0.5% of market cap
- EV/EBITDA multiple is 25.3x compared to historical level (75th percentile) of 16.3x
- EV/Sales multiple is 5.6x

At the opening of the session the share price went down -6.9% vs S&P500 -0.2%
2025-03-28
#reports #FEMY

[Femasys Inc.](https://eninvs.com/all.php?name=FEMY) (Medical Instruments and Supplies) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182619)
(2025-03-27, Before Market Open):

- Revenue +52% YoY (vs +127.5% in previous quarter and historical rate +56.2%)
- EBITDA margin -1073.5% increased compared to -1308.3% same period last year
- Net Debt increased by $4.4 bln since the start of the year (27677.1% of market cap)
- FCF (LTM) -$14.6 bln (negative), 92834.0% of market cap
- EV/Sales multiple is 1.5x

At the opening of the session the share price went down -4.6% vs S&P500 -0.3%
2025-03-28
#reports #BKTI

[BK Technologies Corporation](https://eninvs.com/all.php?name=BKTI) (Communication Equipment) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182676)
(2023-05-11, Before Market Open):

- Revenue +12.5% YoY (vs 0.0% in previous quarter and historical rate +29.1%)
- EBITDA margin 16.7% increased compared to 6.3% same period last year
- Net Debt decreased by $3 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 1.5% of market cap
- EV/EBITDA multiple is 64.5x compared to historical level (75th percentile) of 188x
- EV/Sales multiple is 7.1x

At the opening of the session the share price went down -2.2%
2025-03-28
#reports #AWH

[Aspira Women's Health](https://eninvs.com/all.php?name=AWH) (Treatments for gynecological problems developer ) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182682)
(2023-08-14, Before Market Open):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +8.3%)
- EBITDA margin -100.0% increased compared to -150.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (98.4% of market cap)
- FCF (LTM) +$0 bln (positive), 98.4% of market cap
- EV/Sales multiple is 0.4x

At the opening of the session the share price went up +0.6%
2025-03-28
#reports #ABUS

[Arbutus Biopharma Corporation](https://eninvs.com/all.php?name=ABUS) (Biotechnology) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182614)
(2025-03-24, Before Market Open):

- Revenue +150% YoY (vs -80.0% in previous quarter and historical rate +30.4%)
- EBITDA margin -1100.0% increased compared to -3500.0% same period last year
- Net Debt increased by $8 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) -$0 bln (negative), 0.4% of market cap
- EV/Sales multiple is 34.3x

2025-03-28
#dividend #ARR

ARMOUR Residential REIT will pay dividends in the amount of 0.24 USD per share on 2025-04-14, which is 1.4% of the current price 17.58. Together with previous payments, the annual dividend yield will be 13.7%

(2025-01-14: 0.72 USD)
(2024-10-14: 0.72 USD)
(2024-07-12: 0.72 USD)
2025-03-27
#reports #WOOF

[Petco Health and Wellness Company, Inc.](https://eninvs.com/all.php?name=WOOF) (Specialty Retail) reported for 2024 q4
(2025-03-26, After Market Close):

- Revenue -7.3% YoY (vs +1.1% in previous quarter and historical rate +1.8%)
- EBITDA +30.8% YoY (vs +5300.0% in previous quarter and historical rate -16.8%)
- EBITDA margin 4.4% increased compared to 3.1% same period last year
- Net Debt decreased by $109 mln over the past reporting period (16.3% of market cap)
- FCF (LTM) -$0 bln (negative), 0.9% of market cap
- EV/EBITDA multiple is 16.6x compared to historical level (75th percentile) of 16x
- EV/Sales multiple is 0.6x

2025-03-27
#reports #VRNT

[Verint Systems](https://eninvs.com/all.php?name=VRNT) (Software developer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182579)
(2025-03-26, After Market Close):

- Revenue -4.2% YoY (vs +2.3% in previous quarter and historical rate +1.4%)
- EBITDA +40.5% YoY (vs -32.5% in previous quarter and historical rate +14.3%)
- EBITDA margin 23.2% increased compared to 15.8% same period last year
- Net Debt increased by $664 mln over the past reporting period (49.4% of market cap)
- EV/EBITDA multiple is 13x compared to historical level (75th percentile) of 27.6x
- EV/Sales multiple is 2.2x

2025-03-27
#reports #VBFC

[Village Bank and Trust Financial](https://eninvs.com/all.php?name=VBFC) (Banks — Regional) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182587)
(2025-01-29, After Market Close):

- Revenue 0% YoY (vs +16.7% in previous quarter and historical rate -5.9%)
- Net Income -50% YoY (vs +100.0% in previous quarter and historical rate -11.8%)
- Net Income margin 14.3% decreased compared to 28.6% same period last year
- P/E multiple is 11.7x compared to historical level (75th percentile) of 14.2x
- P/S multiple is 4.3x
- Price to book: 1.6x

At the opening of the session the share price went down -0.5% vs S&P500 +0.2%
2025-03-27
#reports #TH

[Target Hospitality](https://eninvs.com/all.php?name=TH) (Oil and Gas Equipment and Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182578)
(2025-03-26, Before Market Open):

- Revenue -33.3% YoY (vs -34.9% in previous quarter and historical rate +21.2%)
- EBITDA -50% YoY (vs -62.8% in previous quarter and historical rate +44.3%)
- EBITDA margin 29.8% decreased compared to 39.7% same period last year
- Net Debt decreased by $191 mln over the past reporting period (29.2% of market cap)
- FCF (LTM) +$0.1 bln (positive), 15.0% of market cap
- EV/EBITDA multiple is 4.4x compared to historical level (75th percentile) of 7.4x
- EV/Sales multiple is 1.7x

At the opening of the session the share price went up +8.2% vs S&P500 -0.1%
2025-03-27
#reports #SONX

[Sonendo, Inc.](https://eninvs.com/all.php?name=SONX) (Medical Devices) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182590)
(2025-03-19, After Market Close):

- Revenue +300% YoY (vs -20.0% in previous quarter and historical rate +5.1%)
- EBITDA margin -75.0% increased compared to -550.0% same period last year
- Net Debt increased by $4 mln over the past reporting period (2.5% of market cap)
- FCF (LTM) -$0 bln (negative), 5.5% of market cap
- EV/Sales multiple is 5.5x

2025-03-27
#reports #OPTN

[OptiNose](https://eninvs.com/all.php?name=OPTN) (Drug Manufacturers — Specialty and Generic) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182576)
(2025-03-06, Before Market Open):

- Revenue +10% YoY (vs -60.8% in previous quarter and historical rate +10.3%)
- EBITDA margin 4.5% increased compared to -10.0% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.6% of market cap
- EV/Sales multiple is 21.3x

At the opening of the session the share price went up +0.7% vs S&P500 -1.0%